Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2 | PLOS ONE
Cytarabine (U-19920A) | ≥99%(HPLC) | Selleck | DNA/RNA Synthesis inhibitor
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy
Chemotherapy dosing schedule. The schedule for ARA-C (200 mg/m 2 /d),... | Download Scientific Diagram
Vector Art - Cytarabine (cytosine arabinoside, ara-c) chemotherapy drug molecule. used in treatment of acute myeloid leukemia (aml), acute lymphocytic leukemia (all) and lymphoma. Clipart Drawing gg75682591 - GoGraph
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Photo - Alamy
Subcut Cytarabine (Ara-C) Shared Care and Community
Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule. Used in Treatment of Acute Myeloid Leukemia (AML), Acute Stock Illustration - Illustration of nonhodgkin, medicinal: 188460910
Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Cytarabine as Chemotherapy Literature Cited Future Treatment of Cytarabine Background: Acute Myeloid Leukemia Mechanism of Actio
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Atoms are represented as spheres with conventional color coding: hydrogen (white),
Cytabarine: Uses and more
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study | Leukemia
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells - Journal of Lipid Research
Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug Stock Vector (Royalty Free) 791676376 | Shutterstock
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience - ScienceDirect
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Cytarabine - Wikipedia
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports
Chemotherapy pre-treatment sensitizes AML cells to DNT-mediated... | Download Scientific Diagram
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
